IRVINE, Calif., June 30, 2023 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company’s management team will participate at the SVB Securities Therapeutics Forum. SVB Securities Therapeutics ForumDate: Tuesday, July 11th – Wednesday,… Continue reading Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
